TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Cancer Biopsy Market Insights, Forecast to 2028

Global Cancer Biopsy Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 27 August 2022
  • Pages :117
  • Formats:
  • Report Code:SMR-7298582
OfferClick for best price

Best Price: $3920

Cancer Biopsy Market Size, Share 2022


Market Analysis and Insights: Global Cancer Biopsy Market

The global Cancer Biopsy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Biopsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Biopsy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Biopsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Biopsy market.

Global Cancer Biopsy Scope and Market Size

Cancer Biopsy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Tissue Biopsies

Liquid Biopsies

Others

Segment by Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Others

By Company

Qiagen N.V.

Illumina, Inc.

ANGLE Plc

Myriad Genetics

Hologic, Inc.

Biocept, Inc.

Thermo Fisher Scientific, Inc.

Danaher

Lucence Diagnostics Pte. Ltd.

GRAIL, Inc.

Guardant Health

Exact Sciences Corporation

Freenome Holdings, Inc.

Oncimmune

Chronix Biomedical, Inc.

Personal Genome Diagnostics Inc.

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Cancer Biopsy product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Cancer Biopsy, with price, sales, revenue, and global market share of Cancer Biopsy from 2019 to 2022.

Chapter 3, the Cancer Biopsy competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Cancer Biopsy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Cancer Biopsy market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Biopsy.

Chapter 13, 14, and 15, to describe Cancer Biopsy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Cancer Biopsy Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Cancer Biopsy Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 117 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biopsy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tissue Biopsies
1.2.3 Liquid Biopsies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Biopsy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Cervical Cancers
1.3.5 Lung Cancers
1.3.6 Prostate Cancers
1.3.7 Skin Cancers
1.3.8 Blood Cancers
1.3.9 Kidney Cancers
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Biopsy Market Perspective (2017-2028)
2.2 Cancer Biopsy Growth Trends by Region
2.2.1 Cancer Biopsy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Biopsy Historic Market Size by Region (2017-2022)
2.2.3 Cancer Biopsy Forecasted Market Size by Region (2023-2028)
2.3 Cancer Biopsy Market Dynamics
2.3.1 Cancer Biopsy Industry Trends
2.3.2 Cancer Biopsy Market Drivers
2.3.3 Cancer Biopsy Market Challenges
2.3.4 Cancer Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Biopsy Players by Revenue
3.1.1 Global Top Cancer Biopsy Players by Revenue (2017-2022)
3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Biopsy Revenue
3.4 Global Cancer Biopsy Market Concentration Ratio
3.4.1 Global Cancer Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biopsy Revenue in 2021
3.5 Cancer Biopsy Key Players Head office and Area Served
3.6 Key Players Cancer Biopsy Product Solution and Service
3.7 Date of Enter into Cancer Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biopsy Breakdown Data by Type
4.1 Global Cancer Biopsy Historic Market Size by Type (2017-2022)
4.2 Global Cancer Biopsy Forecasted Market Size by Type (2023-2028)
5 Cancer Biopsy Breakdown Data by Application
5.1 Global Cancer Biopsy Historic Market Size by Application (2017-2022)
5.2 Global Cancer Biopsy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Biopsy Market Size (2017-2028)
6.2 North America Cancer Biopsy Market Size by Type
6.2.1 North America Cancer Biopsy Market Size by Type (2017-2022)
6.2.2 North America Cancer Biopsy Market Size by Type (2023-2028)
6.2.3 North America Cancer Biopsy Market Share by Type (2017-2028)
6.3 North America Cancer Biopsy Market Size by Application
6.3.1 North America Cancer Biopsy Market Size by Application (2017-2022)
6.3.2 North America Cancer Biopsy Market Size by Application (2023-2028)
6.3.3 North America Cancer Biopsy Market Share by Application (2017-2028)
6.4 North America Cancer Biopsy Market Size by Country
6.4.1 North America Cancer Biopsy Market Size by Country (2017-2022)
6.4.2 North America Cancer Biopsy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Biopsy Market Size (2017-2028)
7.2 Europe Cancer Biopsy Market Size by Type
7.2.1 Europe Cancer Biopsy Market Size by Type (2017-2022)
7.2.2 Europe Cancer Biopsy Market Size by Type (2023-2028)
7.2.3 Europe Cancer Biopsy Market Share by Type (2017-2028)
7.3 Europe Cancer Biopsy Market Size by Application
7.3.1 Europe Cancer Biopsy Market Size by Application (2017-2022)
7.3.2 Europe Cancer Biopsy Market Size by Application (2023-2028)
7.3.3 Europe Cancer Biopsy Market Share by Application (2017-2028)
7.4 Europe Cancer Biopsy Market Size by Country
7.4.1 Europe Cancer Biopsy Market Size by Country (2017-2022)
7.4.2 Europe Cancer Biopsy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Biopsy Market Size (2017-2028)
8.2 Asia-Pacific Cancer Biopsy Market Size by Type
8.2.1 Asia-Pacific Cancer Biopsy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cancer Biopsy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cancer Biopsy Market Share by Type (2017-2028)
8.3 Asia-Pacific Cancer Biopsy Market Size by Application
8.3.1 Asia-Pacific Cancer Biopsy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cancer Biopsy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cancer Biopsy Market Share by Application (2017-2028)
8.4 Asia-Pacific Cancer Biopsy Market Size by Region
8.4.1 Asia-Pacific Cancer Biopsy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cancer Biopsy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Biopsy Market Size (2017-2028)
9.2 Latin America Cancer Biopsy Market Size by Type
9.2.1 Latin America Cancer Biopsy Market Size by Type (2017-2022)
9.2.2 Latin America Cancer Biopsy Market Size by Type (2023-2028)
9.2.3 Latin America Cancer Biopsy Market Share by Type (2017-2028)
9.3 Latin America Cancer Biopsy Market Size by Application
9.3.1 Latin America Cancer Biopsy Market Size by Application (2017-2022)
9.3.2 Latin America Cancer Biopsy Market Size by Application (2023-2028)
9.3.3 Latin America Cancer Biopsy Market Share by Application (2017-2028)
9.4 Latin America Cancer Biopsy Market Size by Country
9.4.1 Latin America Cancer Biopsy Market Size by Country (2017-2022)
9.4.2 Latin America Cancer Biopsy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Biopsy Market Size (2017-2028)
10.2 Middle East & Africa Cancer Biopsy Market Size by Type
10.2.1 Middle East & Africa Cancer Biopsy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cancer Biopsy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cancer Biopsy Market Share by Type (2017-2028)
10.3 Middle East & Africa Cancer Biopsy Market Size by Application
10.3.1 Middle East & Africa Cancer Biopsy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cancer Biopsy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cancer Biopsy Market Share by Application (2017-2028)
10.4 Middle East & Africa Cancer Biopsy Market Size by Country
10.4.1 Middle East & Africa Cancer Biopsy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cancer Biopsy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Details
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Cancer Biopsy Introduction
11.1.4 Qiagen N.V. Revenue in Cancer Biopsy Business (2017-2022)
11.1.5 Qiagen N.V. Recent Developments
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Details
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Cancer Biopsy Introduction
11.2.4 Illumina, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.2.5 Illumina, Inc. Recent Developments
11.3 ANGLE Plc
11.3.1 ANGLE Plc Company Details
11.3.2 ANGLE Plc Business Overview
11.3.3 ANGLE Plc Cancer Biopsy Introduction
11.3.4 ANGLE Plc Revenue in Cancer Biopsy Business (2017-2022)
11.3.5 ANGLE Plc Recent Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Cancer Biopsy Introduction
11.4.4 Myriad Genetics Revenue in Cancer Biopsy Business (2017-2022)
11.4.5 Myriad Genetics Recent Developments
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Details
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Cancer Biopsy Introduction
11.5.4 Hologic, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.5.5 Hologic, Inc. Recent Developments
11.6 Biocept, Inc.
11.6.1 Biocept, Inc. Company Details
11.6.2 Biocept, Inc. Business Overview
11.6.3 Biocept, Inc. Cancer Biopsy Introduction
11.6.4 Biocept, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.6.5 Biocept, Inc. Recent Developments
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Details
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.7.5 Thermo Fisher Scientific, Inc. Recent Developments
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Cancer Biopsy Introduction
11.8.4 Danaher Revenue in Cancer Biopsy Business (2017-2022)
11.8.5 Danaher Recent Developments
11.9 Lucence Diagnostics Pte. Ltd.
11.9.1 Lucence Diagnostics Pte. Ltd. Company Details
11.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Introduction
11.9.4 Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2017-2022)
11.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments
11.10 GRAIL, Inc.
11.10.1 GRAIL, Inc. Company Details
11.10.2 GRAIL, Inc. Business Overview
11.10.3 GRAIL, Inc. Cancer Biopsy Introduction
11.10.4 GRAIL, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.10.5 GRAIL, Inc. Recent Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Details
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Cancer Biopsy Introduction
11.11.4 Guardant Health Revenue in Cancer Biopsy Business (2017-2022)
11.11.5 Guardant Health Recent Developments
11.12 Exact Sciences Corporation
11.12.1 Exact Sciences Corporation Company Details
11.12.2 Exact Sciences Corporation Business Overview
11.12.3 Exact Sciences Corporation Cancer Biopsy Introduction
11.12.4 Exact Sciences Corporation Revenue in Cancer Biopsy Business (2017-2022)
11.12.5 Exact Sciences Corporation Recent Developments
11.13 Freenome Holdings, Inc.
11.13.1 Freenome Holdings, Inc. Company Details
11.13.2 Freenome Holdings, Inc. Business Overview
11.13.3 Freenome Holdings, Inc. Cancer Biopsy Introduction
11.13.4 Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.13.5 Freenome Holdings, Inc. Recent Developments
11.14 Oncimmune
11.14.1 Oncimmune Company Details
11.14.2 Oncimmune Business Overview
11.14.3 Oncimmune Cancer Biopsy Introduction
11.14.4 Oncimmune Revenue in Cancer Biopsy Business (2017-2022)
11.14.5 Oncimmune Recent Developments
11.15 Chronix Biomedical, Inc.
11.15.1 Chronix Biomedical, Inc. Company Details
11.15.2 Chronix Biomedical, Inc. Business Overview
11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Introduction
11.15.4 Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.15.5 Chronix Biomedical, Inc. Recent Developments
11.16 Personal Genome Diagnostics Inc.
11.16.1 Personal Genome Diagnostics Inc. Company Details
11.16.2 Personal Genome Diagnostics Inc. Business Overview
11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Introduction
11.16.4 Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.16.5 Personal Genome Diagnostics Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Cancer Biopsy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tissue Biopsies
Table 3. Key Players of Liquid Biopsies
Table 4. Key Players of Others
Table 5. Global Cancer Biopsy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Cancer Biopsy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cancer Biopsy Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cancer Biopsy Market Share by Region (2017-2022)
Table 9. Global Cancer Biopsy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cancer Biopsy Market Share by Region (2023-2028)
Table 11. Cancer Biopsy Market Trends
Table 12. Cancer Biopsy Market Drivers
Table 13. Cancer Biopsy Market Challenges
Table 14. Cancer Biopsy Market Restraints
Table 15. Global Cancer Biopsy Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cancer Biopsy Revenue Share by Players (2017-2022)
Table 17. Global Top Cancer Biopsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2021)
Table 18. Ranking of Global Top Cancer Biopsy Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cancer Biopsy Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Biopsy Product Solution and Service
Table 22. Date of Enter into Cancer Biopsy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cancer Biopsy Revenue Market Share by Type (2017-2022)
Table 26. Global Cancer Biopsy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cancer Biopsy Revenue Market Share by Type (2023-2028)
Table 28. Global Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cancer Biopsy Revenue Share by Application (2017-2022)
Table 30. Global Cancer Biopsy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cancer Biopsy Revenue Share by Application (2023-2028)
Table 32. North America Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Cancer Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Cancer Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Cancer Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Cancer Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Cancer Biopsy Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Cancer Biopsy Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Cancer Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Cancer Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Cancer Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Cancer Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 62. Qiagen N.V. Company Details
Table 63. Qiagen N.V. Business Overview
Table 64. Qiagen N.V. Cancer Biopsy Product
Table 65. Qiagen N.V. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 66. Qiagen N.V. Recent Developments
Table 67. Illumina, Inc. Company Details
Table 68. Illumina, Inc. Business Overview
Table 69. Illumina, Inc. Cancer Biopsy Product
Table 70. Illumina, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 71. Illumina, Inc. Recent Developments
Table 72. ANGLE Plc Company Details
Table 73. ANGLE Plc Business Overview
Table 74. ANGLE Plc Cancer Biopsy Product
Table 75. ANGLE Plc Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 76. ANGLE Plc Recent Developments
Table 77. Myriad Genetics Company Details
Table 78. Myriad Genetics Business Overview
Table 79. Myriad Genetics Cancer Biopsy Product
Table 80. Myriad Genetics Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 81. Myriad Genetics Recent Developments
Table 82. Hologic, Inc. Company Details
Table 83. Hologic, Inc. Business Overview
Table 84. Hologic, Inc. Cancer Biopsy Product
Table 85. Hologic, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 86. Hologic, Inc. Recent Developments
Table 87. Biocept, Inc. Company Details
Table 88. Biocept, Inc. Business Overview
Table 89. Biocept, Inc. Cancer Biopsy Product
Table 90. Biocept, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 91. Biocept, Inc. Recent Developments
Table 92. Thermo Fisher Scientific, Inc. Company Details
Table 93. Thermo Fisher Scientific, Inc. Business Overview
Table 94. Thermo Fisher Scientific, Inc. Cancer Biopsy Product
Table 95. Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 96. Thermo Fisher Scientific, Inc. Recent Developments
Table 97. Danaher Company Details
Table 98. Danaher Business Overview
Table 99. Danaher Cancer Biopsy Product
Table 100. Danaher Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 101. Danaher Recent Developments
Table 102. Lucence Diagnostics Pte. Ltd. Company Details
Table 103. Lucence Diagnostics Pte. Ltd. Business Overview
Table 104. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product
Table 105. Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 106. Lucence Diagnostics Pte. Ltd. Recent Developments
Table 107. GRAIL, Inc. Company Details
Table 108. GRAIL, Inc. Business Overview
Table 109. GRAIL, Inc. Cancer Biopsy Product
Table 110. GRAIL, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 111. GRAIL, Inc. Recent Developments
Table 112. Guardant Health Company Details
Table 113. Guardant Health Business Overview
Table 114. Guardant Health Cancer Biopsy Product
Table 115. Guardant Health Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 116. Guardant Health Recent Developments
Table 117. Exact Sciences Corporation Company Details
Table 118. Exact Sciences Corporation Business Overview
Table 119. Exact Sciences Corporation Cancer Biopsy Product
Table 120. Exact Sciences Corporation Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 121. Exact Sciences Corporation Recent Developments
Table 122. Freenome Holdings, Inc. Company Details
Table 123. Freenome Holdings, Inc. Business Overview
Table 124. Freenome Holdings, Inc. Cancer Biopsy Product
Table 125. Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 126. Freenome Holdings, Inc. Recent Developments
Table 127. Oncimmune Company Details
Table 128. Oncimmune Business Overview
Table 129. Oncimmune Cancer Biopsy Product
Table 130. Oncimmune Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 131. Oncimmune Recent Developments
Table 132. Chronix Biomedical, Inc. Company Details
Table 133. Chronix Biomedical, Inc. Business Overview
Table 134. Chronix Biomedical, Inc. Cancer Biopsy Product
Table 135. Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 136. Chronix Biomedical, Inc. Recent Developments
Table 137. Personal Genome Diagnostics Inc. Company Details
Table 138. Personal Genome Diagnostics Inc. Business Overview
Table 139. Personal Genome Diagnostics Inc. Cancer Biopsy Product
Table 140. Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
Table 141. Personal Genome Diagnostics Inc. Recent Developments
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Biopsy Market Share by Type: 2021 VS 2028
Figure 2. Tissue Biopsies Features
Figure 3. Liquid Biopsies Features
Figure 4. Others Features
Figure 5. Global Cancer Biopsy Market Share by Application: 2021 VS 2028
Figure 6. Breast Cancer Case Studies
Figure 7. Colorectal Cancer Case Studies
Figure 8. Cervical Cancers Case Studies
Figure 9. Lung Cancers Case Studies
Figure 10. Prostate Cancers Case Studies
Figure 11. Skin Cancers Case Studies
Figure 12. Blood Cancers Case Studies
Figure 13. Kidney Cancers Case Studies
Figure 14. Others Case Studies
Figure 15. Cancer Biopsy Report Years Considered
Figure 16. Global Cancer Biopsy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Cancer Biopsy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Cancer Biopsy Market Share by Region: 2021 VS 2028
Figure 19. Global Cancer Biopsy Market Share by Players in 2021
Figure 20. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Cancer Biopsy Revenue in 2021
Figure 22. North America Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
Figure 23. North America Cancer Biopsy Market Size Market Share by Type (2017-2028)
Figure 24. North America Cancer Biopsy Market Size Market Share by Application (2017-2028)
Figure 25. North America Cancer Biopsy Market Size Share by Country (2017-2028)
Figure 26. United States Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Canada Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
Figure 29. Europe Cancer Biopsy Market Size Market Share by Type (2017-2028)
Figure 30. Europe Cancer Biopsy Market Size Market Share by Application (2017-2028)
Figure 31. Europe Cancer Biopsy Market Size Share by Country (2017-2028)
Figure 32. Germany Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
Figure 39. Asia Pacific Cancer Biopsy Market Size Market Share by Type (2017-2028)
Figure 40. Asia Pacific Cancer Biopsy Market Size Market Share by Application (2017-2028)
Figure 41. Asia Pacific Cancer Biopsy Market Size Share by Region (2017-2028)
Figure 42. China Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 48. Latin America Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Latin America Cancer Biopsy Market Size Market Share by Type (2017-2028)
Figure 50. Latin America Cancer Biopsy Market Size Market Share by Application (2017-2028)
Figure 51. Latin America Cancer Biopsy Market Size Share by Country (2017-2028)
Figure 52. Mexico Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Brazil Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Cancer Biopsy Market Size Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Cancer Biopsy Market Size Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Cancer Biopsy Market Size Share by Country (2017-2028)
Figure 58. Turkey Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UAE Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. Qiagen N.V. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 62. Illumina, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 63. ANGLE Plc Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 64. Myriad Genetics Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 65. Hologic, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 66. Biocept, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 67. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 68. Danaher Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 69. Lucence Diagnostics Pte. Ltd. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 70. GRAIL, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 71. Guardant Health Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 72. Exact Sciences Corporation Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 73. Freenome Holdings, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 74. Oncimmune Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 75. Chronix Biomedical, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 76. Personal Genome Diagnostics Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount